{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:47:52Z","timestamp":1774532872919,"version":"3.50.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Geisinger, Summer Research Immersion Program (SRIP).","award":["2019:01"],"award-info":[{"award-number":["2019:01"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>First discovered in 1990, the endocannabinoid system (ECS) was initially shown to have an intimate relationship with central areas of the nervous system associated with pain, reward, and motivation. Recently, however, the ECS has been extensively implicated in the cardiovascular system with contractility, heart rate, blood pressure, and vasodilation. Emerging data demonstrate modulation of the ECS plays an essential role in cardio metabolic risk, atherosclerosis, and can even limit damage to cardiomyocytes during ischemic events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Concerns:<\/jats:title>\n            <jats:p>This case describes a 63-year-old man who presented to a primary care physician for a medical cannabis (MC) consult due to unstable angina (UA) not relieved by morphine or cardiac medications; having failed all first- and second-line polypharmaceutical therapies. The patient reported frequent, unprovoked, angina and exertional dyspnea.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Having a complex cardiac history, the patient first presented 22\u200ayears ago after a suspected myocardial infarction. He re-presented in 2010 and underwent stent placement at that time for inoperable triple-vessel coronary artery disease (CAD) which was identified via percutaneous transluminal coronary angioplasty. UA developed on follow-up and, despite medical management over the past 6\u200ayears, became progressively debilitating.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and Outcomes:<\/jats:title>\n            <jats:p>In conjunction with his standard cardiac care, patient had a gradual lessening of UA-related pain, including frequency and character, after using an edible form of MC (1:1 cannabidiol:\u0394<jats:sup>9<\/jats:sup>-tetrahydrocannabinol). Following continued treatment, he ceased long-term morphine treatment and described the pain as no longer crippling. As demonstrated by his exercise tolerance tests, the patient experienced an improved functional capacity and reported an increase in his daily functioning, and overall activity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case uniquely highlights MC in possibly reducing the character, quality, and frequency of UA, whereas concordantly improving functional cardiac capacity in a patient with CAD. Additional case reports are necessary to verify this.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025172","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T21:58:19Z","timestamp":1615931899000},"page":"e25172","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Application of medical cannabis in unstable angina and coronary artery disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Brian L.","family":"Shaffer","sequence":"first","affiliation":[{"name":"Center for Primary Care Medicine, Lawrenceville, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrison M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Geisinger Commonwealth School of Medicine, Scranton"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Incitti","sequence":"additional","affiliation":[{"name":"Geisinger Commonwealth School of Medicine, Scranton"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Piper","sequence":"additional","affiliation":[{"name":"Geisinger Commonwealth School of Medicine, Scranton"},{"name":"Center for Pharmacy Innovation and Outcomes, Forty Fort, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-8542","authenticated-orcid":false,"given":"Brian V.","family":"Entler","sequence":"additional","affiliation":[{"name":"Geisinger Commonwealth School of Medicine, Scranton"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R2-20250504","first-page":"14","article-title":"Getting high on the endocannabinoid system","volume":"2013","author":"Alger","year":"2013","journal-title":"Cerebrum"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.21037\/jtd.2017.06.104","article-title":"Role of cannabis in cardiovascular disorders","volume":"9","author":"Goyal","year":"2017","journal-title":"J Thorac Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/HYPERTENSIONAHA.105.063651","article-title":"Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations","volume":"52","author":"Pacher","year":"2008","journal-title":"Hypertension"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.yjmcc.2009.10.025","article-title":"Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure","volume":"48","author":"Weis","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2018.03.015","article-title":"Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure","volume":"122","author":"Adegbala","year":"2018","journal-title":"Am J Cardiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1751-7133.2008.00016.x","article-title":"CB1 cannabinoid receptor inhibition: promising approach for heart failure?","volume":"14","author":"Mukhopadhyay","year":"2008","journal-title":"Congest Heart Fail"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"bcr2014207020","DOI":"10.1136\/bcr-2014-207020","article-title":"Myocardial infarction following cannabis induced coronary vasospasm","volume":"2014","author":"Gunawardena","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2459\/JCM.0000000000000681","article-title":"Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample","volume":"19","author":"Kalla","year":"2018","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/emj.2004.014969","article-title":"Cardiovascular complications induced by cannabis smoking: a case report and review of the literature","volume":"22","author":"Fisher","year":"2005","journal-title":"Emerg Med J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:29:24Z","timestamp":1746340164000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025172"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025172","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2020-11-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}